Regulations

Description: 
A forum for sharing on Prescription Monitoring Programs
Source: 
Alliance of States with Prescription Monitoring Programs
field_vote: 
Description: 
The DEA revised regulations to allow electronic prescriptions for controlled substances.
Source: 
Drug Enforcement Administration and Department of Justice
field_vote: 
Description: 
Official federal regulations concerning the use of controlled substances. The regulations address registration, prescription, and schedules of controlled substances, among other topics pertaining to controlled substances.
Source: 
National Archives and Records Administration
field_vote: 
Description: 
Describes programs to dispose of unused pain medications and other prescription medications.
Source: 
FDA
field_vote: 
Patient Handouts: 
Description: 
This handout discusses how a prescribing physician may prepare for a visit from the DEA. Such visits are required by law for physicians prescribing buprenorphine, and involve things such as prescription and dispensing records, and adherence to prescribing limits on number of patients.
Source: 
PCSS
field_vote: 
Physician stage in practice: 
Commonly Used Forms: 

Listing of State Agencies and Organizations

Description: 
A listing of websites and other contact information for state agencies that regulate substance dependence treatment. Many provide resources to assist patients or physicians in identifying treatment providers.
field_vote: 
Commonly Used Forms: 
Description: 
This clinical guidance provides information about the requirements for storing, dispensing, and maintaining records for physicians who provide office-based opioid treatment.
Source: 
Physician Clinical Support System (PCSS)
field_vote: 
Physician stage in practice: 
Description: 
Informational checklist designed to aid health care providers in making sure their practice is compliant with HIPAA regulations.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
field_vote: 
Commonly Used Forms: 
Physician stage in practice: 
Description: 
This form dated 2006 was for physicians to notify the DEA (through the Substance Abuse and Mental Health Services Administration) of their intent to use Schedule III, IV, or V drugs for treatment of opioid dependent patients. See SAMHSA's Buprenorphine Waiver Management page for the latest information on what form to use for this purpose.
Source: 
The National Alliance of Advocates for Buprenorphine Treatment (NAABT)
field_vote: 
Resource Type: 
Commonly Used Forms: 
Physician stage in practice: 

Pages

Subscribe to Regulations